1. Home
  2. TUYA vs CGEM Comparison

TUYA vs CGEM Comparison

Compare TUYA & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.25

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$12.11

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
CGEM
Founded
2014
2016
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
671.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TUYA
CGEM
Price
$2.25
$12.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$3.49
$28.00
AVG Volume (30 Days)
1.1M
1.4M
Earning Date
11-24-2025
11-06-2025
Dividend Yield
4.82%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$319,363,000.00
N/A
Revenue This Year
$9.15
N/A
Revenue Next Year
$11.79
N/A
P/E Ratio
$29.14
N/A
Revenue Growth
13.66
N/A
52 Week Low
$1.57
$5.68
52 Week High
$4.63
$13.33

Technical Indicators

Market Signals
Indicator
TUYA
CGEM
Relative Strength Index (RSI) 49.93 63.92
Support Level $2.22 $10.01
Resistance Level $2.31 $13.10
Average True Range (ATR) 0.11 1.21
MACD 0.01 0.09
Stochastic Oscillator 60.76 67.02

Price Performance

Historical Comparison
TUYA
CGEM

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: